Literature DB >> 18418813

Insulin analogues with increased mitogenic potency--are they safe?

B F Hansen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18418813     DOI: 10.1055/s-2008-1062740

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  12 in total

1.  Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years.

Authors:  Haim Werner; Ernst A Chantelau
Journal:  Diabetol Metab Syndr       Date:  2011-06-29       Impact factor: 3.320

2.  Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor.

Authors:  E Yehezkel; D Weinstein; M Simon; R Sarfstein; Z Laron; H Werner
Journal:  Diabetologia       Date:  2010-09-12       Impact factor: 10.122

3.  Diabetes: diabetes therapy and cancer risk.

Authors:  Riccardo Vigneri
Journal:  Nat Rev Endocrinol       Date:  2009-12       Impact factor: 43.330

4.  Light Control of Protein Solubility Through Isoelectric Point Modulation.

Authors:  Karthik Nadendla; Simon H Friedman
Journal:  J Am Chem Soc       Date:  2017-12-01       Impact factor: 15.419

5.  Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues.

Authors:  Tine Glendorf; Louise Knudsen; Carsten E Stidsen; Bo F Hansen; Anne Charlotte Hegelund; Anders R Sørensen; Erica Nishimura; Thomas Kjeldsen
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

6.  Molecular characterisation of long-acting insulin analogues in comparison with human insulin, IGF-1 and insulin X10.

Authors:  Bo F Hansen; Tine Glendorf; Anne C Hegelund; Anders Lundby; Anne Lützen; Rita Slaaby; Carsten Enggaard Stidsen
Journal:  PLoS One       Date:  2012-05-08       Impact factor: 3.240

7.  Alternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cells.

Authors:  Bas ter Braak; Steven Wink; Esmee Koedoot; Chantal Pont; Christine Siezen; Jan Willem van der Laan; Bob van de Water
Journal:  Breast Cancer Res       Date:  2015-07-19       Impact factor: 6.466

8.  A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.

Authors:  Ivona Baricevic; David R Jones; Darren L Roberts; Anne Lutzen; Anders Lundby; Jesper Worm; Bo F Hansen; Andrew G Renehan
Journal:  Carcinogenesis       Date:  2015-05-30       Impact factor: 4.944

Review 9.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

10.  Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation.

Authors:  Vladislav V Kiselyov; Soetkin Versteyhe; Lisbeth Gauguin; Pierre De Meyts
Journal:  Mol Syst Biol       Date:  2009-02-17       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.